BionicM

is a robotics startup based in Japan with a strong mission of "Powering Mobility for All." The company is dedicated to improving mobility for both handicapped and non-handicapped individuals by integrating robotics technology with the human body. Their primary focus lies in developing robotic prostheses for below-limb amputees, aiming to enhance their quality of life and overall mobility. Notably, their flagship product, the Bio Leg, serves as an innovative robotics prosthetic knee designed to meet the specific needs of amputees.

Since its establishment in 2018, BionicM has been at the forefront of innovative technologies, conducting extensive research at the University of Tokyo's Information Systems Engineering Laboratory (JSK) under the guidance of Professor Inaba. This research leverages the world's most advanced robotics technology, positioning the company as a leader in the field. Furthermore, in 2016, BionicM was selected by the Japan Science and Technology Agency as part of the "Program for Creating STart-ups from Advanced Research and Technology" (START), signifying their recognition for pioneering work in the industry.

In January 31, 2023, BionicM successfully secured a ¥370.00M Series A investment, attracting prominent investors such as UTokyo Innovation Platform, SHINSEI CORPORATE INVESTMENT, Kiraboshi Capital, Yoshitsune Ido, Hao Yan, Chibagin Capital, and AIS Partners. This significant investment further underscores the industry's confidence in BionicM's groundbreaking vision and showcases strong support for their future endeavors. With a focus on Manufacturing and Robotics, BionicM is well-positioned to continue spearheading innovative advancements in the mobility sector, promising positive impact and transformative solutions.